Plasma von Willebrand factor and arterial aging [1]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 4, 2005, Pages 794-795

  Vischer, U M ^a,c   Herrmann, F R ^a   Peyrard, T ^a   Nzietchueng, R ^b   Benetos, A ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Hopital de Geriatrie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; EDETIC ACID; NITRIC OXIDE; VON WILLEBRAND FACTOR;

AGING; ARTERY; BLOOD GROUP ABO SYSTEM; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SHEAR STRESS; SYSTOLIC BLOOD PRESSURE; ADULT; AGED; BIOSYNTHESIS; FEMALE; INTIMA; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; STATISTICAL MODEL; TUNICA MEDIA;

ADULT; AGED; AGING; ARTERIES; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TUNICA INTIMA; TUNICA MEDIA; VON WILLEBRAND FACTOR;

EID: 23044477432     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01242.x     Document Type: Letter

References (6)

1. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004; 109: 1343-8.
2. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-41.
3. Vischer UM, de Moerloose P. von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease. Crit Rev Oncol Hematol 1999; 30: 93-109.
4. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
5. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, Thomas F, Pannier B, Asmar R, Zureik M, Safar M, Guize L. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105: 1202-7.
6. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998; 82: 1094-101.